Evidence map›Paper›PMID 30700698›Full record

ArticleCell death & disease2019

Downregulation of G2/mitotic-specific cyclinB1 triggers autophagy via AMPK-ULK1-dependent signal pathway in nasopharyngeal carcinoma cells.

Xianhe Xie, Wanzun Lin, Weili Zheng, Ting Chen, Haitao Yang, Lijun Sun, Fei Huang, Zili Wang, Heng Lin, Long Chen and 2 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Xianhe XieDepartment of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China. xiexianhe@yahoo.com.
Wanzun LinDepartment of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China.
Weili ZhengDepartment of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China.
Ting ChenDepartment of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China.
Haitao YangDepartment of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China.
Lijun SunDepartment of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China.
Fei HuangDepartment of Central Laboratory, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China.
Zili WangDepartment of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China.
Heng LinDepartment of Chemotherapy, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China.
Long ChenDepartment of Intensive Care Unit, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China.
Jun LiuDepartment of Central Laboratory, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China.
Liyan YangDepartment of Nephrology, The First Affiliated Hospital of Fujian Medical University, 20th Chazhong Road, 350005, Fuzhou, Fujian, China.
First Affiliated Hospital of Fujian Medical University · CNFujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

CyclinB1 is a regulatory protein involved in mitosis. Multiple lines of evidence indicate that cyclinB1 depletion constrains proliferation and induces apoptosis in human tumor cells. The cells become susceptible to suffer a critical situation when cyclinB1 is downregulated. Autophagy is a major intracellular degradation system that recycles nutrients, removes damaged organelles, and promotes cell survival under stressful conditions, whereas the role of autophagy in cyclinB1-deprived neoplastic cell as well as the underlying molecular mechanism remains obscure. Here we pioneeringly elaborated that specific knockdown of cyclinB1 triggered autophagy via AMPK-ULK1-dependent signal pathway through the elevation of ROS, rather than ATP in the cell lines of CNE-1 and CNE-2. Moreover, ROS scavengers demonstrated that the observed effect of cyclinB1 silencing on AMPK phosphorylation was ROS dependent. Additionally, double knockdown of AMPK and cyclinB1 evidently abrogated cyclinB1 silencing-induced autophagy. Summarily, this study first revealed that downregulation of cyclinB1 induced autophagy via AMPK-ULK1-dependent signal pathway, which represents a key step toward unveiling the mechanism how cell cycle checkpoint proteins regulate autophagy.

Indexed as

AMP-Activated Protein KinasesAutophagyCell SurvivalDown-RegulationHumansNasopharyngeal CarcinomaSignal TransductionAMP-Activated Protein Kinases

Identifiers

PMID30700698
PMCPMC6353984
OpenAlexW2914012668

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.